APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical CMC Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical CMC Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026196 pages

Choose your research edition.

Industry ResearchPharmaceutical CMC Services Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical CMC Services Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pharmaceutical CMC Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical CMC Services Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical CMC Services Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Pharmaceutical CMC Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmaceutical CMC Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical CMC Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical CMC Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical CMC Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical CMC Services include PharmaLex, Sterling, Intertek, Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance) and PPD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmaceutical CMC Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical CMC Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical CMC Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical CMC Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical CMC Services Segment by Company

PharmaLex

Sterling

Intertek

Eurofins

WuXi AppTec

Pace Analytical Services

Catalent

LabCorp (Covance)

PPD

Element (Exova)

ALS Pharmaceutical

SGS

Boston Analytical

ProPharma

Ardena

Kymanox Corporation

Lonza

Pharmaron

CTI

Weipu

PONY Medicine

Haoyuan Chemexpress

Porton

Pharmaceutical CMC Services Segment by Type

API Process Development and Production

Pre-formulation Research, Pharmaceutical Development and Production

Analytical Method Development and Stability Research

CMC Registration and Declaration

Other

Pharmaceutical CMC Services Segment by Application

Preclinical

Phase I and II

Phase III

Post-launch

Pharmaceutical CMC Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical CMC Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical CMC Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical CMC Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical CMC Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical CMC Services industry.

Chapter 3: Detailed analysis of Pharmaceutical CMC Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CMC Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical CMC Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of API Process Development and Production Table 3. Key Players of Pre-formulation Research, Pharmaceutical Development and Production Table 4. Key Players of Analytical Method Development and Stability Research Table 3. Key Players of CMC Registration and Declaration Table 4. Key Players of Other Table 5. Global Pharmaceutical CMC Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Preclinical Table 7. Key Players of Phase I and II Table 8. Key Players of Phase III Table 9. Key Players of Post-launch Table 10. Global Pharmaceutical CMC Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Pharmaceutical CMC Services Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Pharmaceutical CMC Services Market Share by Region (2021-2026) Table 13. Global Pharmaceutical CMC Services Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Pharmaceutical CMC Services Market Share by Region (2027-2032) Table 15. Pharmaceutical CMC Services Industry Trends Table 16. Pharmaceutical CMC Services Industry Drivers Table 17. Pharmaceutical CMC Services Industry Opportunities and Challenges Table 18. Pharmaceutical CMC Services Industry Restraints Table 19. Global Pharmaceutical CMC Services Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Pharmaceutical CMC Services Revenue Market Share by Company (2021-2026) Table 21. Global Pharmaceutical CMC Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Pharmaceutical CMC Services Key Company Head Office and Area Served Table 23. Global Pharmaceutical CMC Services Company, Product Type & Application Table 24. Global Pharmaceutical CMC Services Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Pharmaceutical CMC Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Pharmaceutical CMC Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical CMC Services Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical CMC Services Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical CMC Services Revenue Market Share by Type (2021-2026) Table 31. Global Pharmaceutical CMC Services Revenue Market Share by Type (2027-2032) Table 32. Global Pharmaceutical CMC Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical CMC Services Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical CMC Services Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical CMC Services Revenue Market Share by Application (2021-2026) Table 36. Global Pharmaceutical CMC Services Revenue Market Share by Application (2027-2032) Table 37. PharmaLex Company Information Table 38. PharmaLex Business Overview Table 39. PharmaLex Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. PharmaLex Pharmaceutical CMC Services Product Portfolio Table 41. PharmaLex Recent Development Table 42. Sterling Company Information Table 43. Sterling Business Overview Table 44. Sterling Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Sterling Pharmaceutical CMC Services Product Portfolio Table 46. Sterling Recent Development Table 47. Intertek Company Information Table 48. Intertek Business Overview Table 49. Intertek Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Intertek Pharmaceutical CMC Services Product Portfolio Table 51. Intertek Recent Development Table 52. Eurofins Company Information Table 53. Eurofins Business Overview Table 54. Eurofins Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Eurofins Pharmaceutical CMC Services Product Portfolio Table 56. Eurofins Recent Development Table 57. WuXi AppTec Company Information Table 58. WuXi AppTec Business Overview Table 59. WuXi AppTec Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. WuXi AppTec Pharmaceutical CMC Services Product Portfolio Table 61. WuXi AppTec Recent Development Table 62. Pace Analytical Services Company Information Table 63. Pace Analytical Services Business Overview Table 64. Pace Analytical Services Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Pace Analytical Services Pharmaceutical CMC Services Product Portfolio Table 66. Pace Analytical Services Recent Development Table 67. Catalent Company Information Table 68. Catalent Business Overview Table 69. Catalent Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Catalent Pharmaceutical CMC Services Product Portfolio Table 71. Catalent Recent Development Table 72. LabCorp (Covance) Company Information Table 73. LabCorp (Covance) Business Overview Table 74. LabCorp (Covance) Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. LabCorp (Covance) Pharmaceutical CMC Services Product Portfolio Table 76. LabCorp (Covance) Recent Development Table 77. PPD Company Information Table 78. PPD Business Overview Table 79. PPD Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. PPD Pharmaceutical CMC Services Product Portfolio Table 81. PPD Recent Development Table 82. Element (Exova) Company Information Table 83. Element (Exova) Business Overview Table 84. Element (Exova) Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Element (Exova) Pharmaceutical CMC Services Product Portfolio Table 86. Element (Exova) Recent Development Table 87. ALS Pharmaceutical Company Information Table 88. ALS Pharmaceutical Business Overview Table 89. ALS Pharmaceutical Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. ALS Pharmaceutical Pharmaceutical CMC Services Product Portfolio Table 91. ALS Pharmaceutical Recent Development Table 92. SGS Company Information Table 93. SGS Business Overview Table 94. SGS Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. SGS Pharmaceutical CMC Services Product Portfolio Table 96. SGS Recent Development Table 97. Boston Analytical Company Information Table 98. Boston Analytical Business Overview Table 99. Boston Analytical Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Boston Analytical Pharmaceutical CMC Services Product Portfolio Table 101. Boston Analytical Recent Development Table 102. ProPharma Company Information Table 103. ProPharma Business Overview Table 104. ProPharma Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. ProPharma Pharmaceutical CMC Services Product Portfolio Table 106. ProPharma Recent Development Table 107. Ardena Company Information Table 108. Ardena Business Overview Table 109. Ardena Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Ardena Pharmaceutical CMC Services Product Portfolio Table 111. Ardena Recent Development Table 112. Kymanox Corporation Company Information Table 113. Kymanox Corporation Business Overview Table 114. Kymanox Corporation Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Kymanox Corporation Pharmaceutical CMC Services Product Portfolio Table 116. Kymanox Corporation Recent Development Table 117. Lonza Company Information Table 118. Lonza Business Overview Table 119. Lonza Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Lonza Pharmaceutical CMC Services Product Portfolio Table 121. Lonza Recent Development Table 122. Pharmaron Company Information Table 123. Pharmaron Business Overview Table 124. Pharmaron Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. Pharmaron Pharmaceutical CMC Services Product Portfolio Table 126. Pharmaron Recent Development Table 127. CTI Company Information Table 128. CTI Business Overview Table 129. CTI Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. CTI Pharmaceutical CMC Services Product Portfolio Table 131. CTI Recent Development Table 132. Weipu Company Information Table 133. Weipu Business Overview Table 134. Weipu Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 135. Weipu Pharmaceutical CMC Services Product Portfolio Table 136. Weipu Recent Development Table 137. PONY Medicine Company Information Table 138. PONY Medicine Business Overview Table 139. PONY Medicine Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 140. PONY Medicine Pharmaceutical CMC Services Product Portfolio Table 141. PONY Medicine Recent Development Table 142. Haoyuan Chemexpress Company Information Table 143. Haoyuan Chemexpress Business Overview Table 144. Haoyuan Chemexpress Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 145. Haoyuan Chemexpress Pharmaceutical CMC Services Product Portfolio Table 146. Haoyuan Chemexpress Recent Development Table 147. Porton Company Information Table 148. Porton Business Overview Table 149. Porton Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 150. Porton Pharmaceutical CMC Services Product Portfolio Table 151. Porton Recent Development Table 152. North America Pharmaceutical CMC Services Market Size by Type (2021-2026) & (US$ Million) Table 153. North America Pharmaceutical CMC Services Market Size by Type (2027-2032) & (US$ Million) Table 154. North America Pharmaceutical CMC Services Market Size by Application (2021-2026) & (US$ Million) Table 155. North America Pharmaceutical CMC Services Market Size by Application (2027-2032) & (US$ Million) Table 156. North America Pharmaceutical CMC Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. North America Pharmaceutical CMC Services Market Size by Country (2021-2026) Table 158. North America Pharmaceutical CMC Services Market Size by Country (2027-2032) Table 159. Europe Pharmaceutical CMC Services Market Size by Type (2021-2026) & (US$ Million) Table 160. Europe Pharmaceutical CMC Services Market Size by Type (2027-2032) & (US$ Million) Table 161. Europe Pharmaceutical CMC Services Market Size by Application (2021-2026) & (US$ Million) Table 162. Europe Pharmaceutical CMC Services Market Size by Application (2027-2032) & (US$ Million) Table 163. Europe Pharmaceutical CMC Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Europe Pharmaceutical CMC Services Market Size by Country (2021-2026) Table 165. Europe Pharmaceutical CMC Services Market Size by Country (2027-2032) Table 166. China Pharmaceutical CMC Services Market Size by Type (2021-2026) & (US$ Million) Table 167. China Pharmaceutical CMC Services Market Size by Type (2027-2032) & (US$ Million) Table 168. China Pharmaceutical CMC Services Market Size by Application (2021-2026) & (US$ Million) Table 169. China Pharmaceutical CMC Services Market Size by Application (2027-2032) & (US$ Million) Table 170. Asia Pharmaceutical CMC Services Market Size by Type (2021-2026) & (US$ Million) Table 171. Asia Pharmaceutical CMC Services Market Size by Type (2027-2032) & (US$ Million) Table 172. Asia Pharmaceutical CMC Services Market Size by Application (2021-2026) & (US$ Million) Table 173. Asia Pharmaceutical CMC Services Market Size by Application (2027-2032) & (US$ Million) Table 174. Asia Pharmaceutical CMC Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Pharmaceutical CMC Services Market Size by Country (2021-2026) Table 176. Asia Pharmaceutical CMC Services Market Size by Country (2027-2032) Table 177. South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Type (2021-2026) & (US$ Million) Table 178. South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Type (2027-2032) & (US$ Million) Table 179. South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Application (2021-2026) & (US$ Million) Table 180. South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Application (2027-2032) & (US$ Million) Table 181. South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Country (2021-2026) Table 183. South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Country (2027-2032) Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Pharmaceutical CMC Services Product Image Figure 2. Global Pharmaceutical CMC Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmaceutical CMC Services Market Share by Type: 2025 VS 2032 Figure 4. API Process Development and Production Image Figure 5. Pre-formulation Research, Pharmaceutical Development and Production Image Figure 6. Analytical Method Development and Stability Research Image Figure 7. CMC Registration and Declaration Image Figure 8. Other Image Figure 9. Global Pharmaceutical CMC Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Pharmaceutical CMC Services Market Share by Application: 2025 VS 2032 Figure 11. Preclinical Image Figure 12. Phase I and II Image Figure 13. Phase III Image Figure 14. Post-launch Image Figure 15. Global Pharmaceutical CMC Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 17. Global Pharmaceutical CMC Services Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Pharmaceutical CMC Services Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Pharmaceutical CMC Services Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Pharmaceutical CMC Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharmaceutical CMC Services Revenue Market Share by Type (2021-2032) Figure 24. Global Pharmaceutical CMC Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pharmaceutical CMC Services Revenue Market Share by Application (2021-2032) Figure 26. North America Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 27. North America Pharmaceutical CMC Services Market Share by Type (2021-2032) Figure 28. North America Pharmaceutical CMC Services Market Share by Application (2021-2032) Figure 29. North America Pharmaceutical CMC Services Market Share by Country (2021-2032) Figure 30. United States Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 31. Canada Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 33. Europe Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 34. Europe Pharmaceutical CMC Services Market Share by Type (2021-2032) Figure 35. Europe Pharmaceutical CMC Services Market Share by Application (2021-2032) Figure 36. Europe Pharmaceutical CMC Services Market Share by Country (2021-2032) Figure 37. Germany Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 38. France Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 40. Italy Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 41. Russia Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 43. China Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 44. China Pharmaceutical CMC Services Market Share by Type (2021-2032) Figure 45. China Pharmaceutical CMC Services Market Share by Application (2021-2032) Figure 46. Asia Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 47. Asia Pharmaceutical CMC Services Market Share by Type (2021-2032) Figure 48. Asia Pharmaceutical CMC Services Market Share by Application (2021-2032) Figure 49. Asia Pharmaceutical CMC Services Market Share by Country (2021-2032) Figure 50. Japan Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 54. India Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 55. Australia Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Pharmaceutical CMC Services Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Pharmaceutical CMC Services Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Pharmaceutical CMC Services Market Share by Country (2021-2032) Figure 60. Brazil Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 65. UAE Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 67. Chile Pharmaceutical CMC Services Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • API Process Development and Production
  • Pre-formulation Research, Pharmaceutical Development and Production
  • Analytical Method Development and Stability Research
  • CMC Registration and Declaration
  • Other
Applications
  • Preclinical
  • Phase I and II
  • Phase III
  • Post-launch
Companies covered
  • PharmaLex
  • Sterling
  • Intertek
  • Eurofins
  • WuXi AppTec
  • Pace Analytical Services
  • Catalent
  • LabCorp (Covance)
  • PPD
  • Element (Exova)
  • ALS Pharmaceutical
  • SGS
  • Boston Analytical
  • ProPharma
  • Ardena
  • Kymanox Corporation
  • Lonza
  • Pharmaron
  • CTI
  • Weipu
  • PONY Medicine
  • Haoyuan Chemexpress
  • Porton

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmaceutical CMC Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 API Process Development and Production
  5. 1.2.3 Pre-formulation Research, Pharmaceutical Development and Production
  6. 1.2.4 Analytical Method Development and Stability Research
  7. 1.2.5 CMC Registration and Declaration
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Pharmaceutical CMC Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Preclinical
  12. 1.3.3 Phase I and II
  13. 1.3.4 Phase III
  14. 1.3.5 Post-launch
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Pharmaceutical CMC Services Growth Trends by Region
  17. 1.5.1 Global Pharmaceutical CMC Services Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Pharmaceutical CMC Services Market Size by Region (2021-2026)
  19. 1.5.3 Pharmaceutical CMC Services Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Pharmaceutical CMC Services Market Dynamics
  1. 2.1 Pharmaceutical CMC Services Industry Trends
  2. 2.2 Pharmaceutical CMC Services Industry Drivers
  3. 2.3 Pharmaceutical CMC Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical CMC Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmaceutical CMC Services Revenue by Company (2021-2026)
  2. 3.2 Global Pharmaceutical CMC Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmaceutical CMC Services Key Company Head office and Area Served
  4. 3.4 Global Pharmaceutical CMC Services Company, Product Type & Application
  5. 3.5 Global Pharmaceutical CMC Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmaceutical CMC Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmaceutical CMC Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmaceutical CMC Services Tier 1, Tier 2, and Tier 3
4 Pharmaceutical CMC Services Market by Type
  1. 4.1 Global Pharmaceutical CMC Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmaceutical CMC Services Market Size by Type (2021-2032)
  3. 4.3 Global Pharmaceutical CMC Services Market Size Share by Type (2021-2032)
5 Pharmaceutical CMC Services Market by Application
  1. 5.1 Global Pharmaceutical CMC Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical CMC Services Market Size by Application (2021-2032)
  3. 5.3 Global Pharmaceutical CMC Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 PharmaLex
  2. 6.1.1 PharmaLex Company Information
  3. 6.1.2 PharmaLex Business Overview
  4. 6.1.3 PharmaLex Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 PharmaLex Pharmaceutical CMC Services Product Portfolio
  6. 6.1.5 PharmaLex Recent Developments
  7. 6.2 Sterling
  8. 6.2.1 Sterling Company Information
  9. 6.2.2 Sterling Business Overview
  10. 6.2.3 Sterling Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sterling Pharmaceutical CMC Services Product Portfolio
  12. 6.2.5 Sterling Recent Developments
  13. 6.3 Intertek
  14. 6.3.1 Intertek Company Information
  15. 6.3.2 Intertek Business Overview
  16. 6.3.3 Intertek Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Intertek Pharmaceutical CMC Services Product Portfolio
  18. 6.3.5 Intertek Recent Developments
  19. 6.4 Eurofins
  20. 6.4.1 Eurofins Company Information
  21. 6.4.2 Eurofins Business Overview
  22. 6.4.3 Eurofins Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Eurofins Pharmaceutical CMC Services Product Portfolio
  24. 6.4.5 Eurofins Recent Developments
  25. 6.5 WuXi AppTec
  26. 6.5.1 WuXi AppTec Company Information
  27. 6.5.2 WuXi AppTec Business Overview
  28. 6.5.3 WuXi AppTec Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 WuXi AppTec Pharmaceutical CMC Services Product Portfolio
  30. 6.5.5 WuXi AppTec Recent Developments
  31. 6.6 Pace Analytical Services
  32. 6.6.1 Pace Analytical Services Company Information
  33. 6.6.2 Pace Analytical Services Business Overview
  34. 6.6.3 Pace Analytical Services Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pace Analytical Services Pharmaceutical CMC Services Product Portfolio
  36. 6.6.5 Pace Analytical Services Recent Developments
  37. 6.7 Catalent
  38. 6.7.1 Catalent Company Information
  39. 6.7.2 Catalent Business Overview
  40. 6.7.3 Catalent Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Catalent Pharmaceutical CMC Services Product Portfolio
  42. 6.7.5 Catalent Recent Developments
  43. 6.8 LabCorp (Covance)
  44. 6.8.1 LabCorp (Covance) Company Information
  45. 6.8.2 LabCorp (Covance) Business Overview
  46. 6.8.3 LabCorp (Covance) Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 LabCorp (Covance) Pharmaceutical CMC Services Product Portfolio
  48. 6.8.5 LabCorp (Covance) Recent Developments
  49. 6.9 PPD
  50. 6.9.1 PPD Company Information
  51. 6.9.2 PPD Business Overview
  52. 6.9.3 PPD Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 PPD Pharmaceutical CMC Services Product Portfolio
  54. 6.9.5 PPD Recent Developments
  55. 6.10 Element (Exova)
  56. 6.10.1 Element (Exova) Company Information
  57. 6.10.2 Element (Exova) Business Overview
  58. 6.10.3 Element (Exova) Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Element (Exova) Pharmaceutical CMC Services Product Portfolio
  60. 6.10.5 Element (Exova) Recent Developments
  61. 6.11 ALS Pharmaceutical
  62. 6.11.1 ALS Pharmaceutical Company Information
  63. 6.11.2 ALS Pharmaceutical Business Overview
  64. 6.11.3 ALS Pharmaceutical Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 ALS Pharmaceutical Pharmaceutical CMC Services Product Portfolio
  66. 6.11.5 ALS Pharmaceutical Recent Developments
  67. 6.12 SGS
  68. 6.12.1 SGS Company Information
  69. 6.12.2 SGS Business Overview
  70. 6.12.3 SGS Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 SGS Pharmaceutical CMC Services Product Portfolio
  72. 6.12.5 SGS Recent Developments
  73. 6.13 Boston Analytical
  74. 6.13.1 Boston Analytical Company Information
  75. 6.13.2 Boston Analytical Business Overview
  76. 6.13.3 Boston Analytical Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Boston Analytical Pharmaceutical CMC Services Product Portfolio
  78. 6.13.5 Boston Analytical Recent Developments
  79. 6.14 ProPharma
  80. 6.14.1 ProPharma Company Information
  81. 6.14.2 ProPharma Business Overview
  82. 6.14.3 ProPharma Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 ProPharma Pharmaceutical CMC Services Product Portfolio
  84. 6.14.5 ProPharma Recent Developments
  85. 6.15 Ardena
  86. 6.15.1 Ardena Company Information
  87. 6.15.2 Ardena Business Overview
  88. 6.15.3 Ardena Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Ardena Pharmaceutical CMC Services Product Portfolio
  90. 6.15.5 Ardena Recent Developments
  91. 6.16 Kymanox Corporation
  92. 6.16.1 Kymanox Corporation Company Information
  93. 6.16.2 Kymanox Corporation Business Overview
  94. 6.16.3 Kymanox Corporation Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Kymanox Corporation Pharmaceutical CMC Services Product Portfolio
  96. 6.16.5 Kymanox Corporation Recent Developments
  97. 6.17 Lonza
  98. 6.17.1 Lonza Company Information
  99. 6.17.2 Lonza Business Overview
  100. 6.17.3 Lonza Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Lonza Pharmaceutical CMC Services Product Portfolio
  102. 6.17.5 Lonza Recent Developments
  103. 6.18 Pharmaron
  104. 6.18.1 Pharmaron Company Information
  105. 6.18.2 Pharmaron Business Overview
  106. 6.18.3 Pharmaron Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Pharmaron Pharmaceutical CMC Services Product Portfolio
  108. 6.18.5 Pharmaron Recent Developments
  109. 6.19 CTI
  110. 6.19.1 CTI Company Information
  111. 6.19.2 CTI Business Overview
  112. 6.19.3 CTI Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 CTI Pharmaceutical CMC Services Product Portfolio
  114. 6.19.5 CTI Recent Developments
  115. 6.20 Weipu
  116. 6.20.1 Weipu Company Information
  117. 6.20.2 Weipu Business Overview
  118. 6.20.3 Weipu Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Weipu Pharmaceutical CMC Services Product Portfolio
  120. 6.20.5 Weipu Recent Developments
  121. 6.21 PONY Medicine
  122. 6.21.1 PONY Medicine Company Information
  123. 6.21.2 PONY Medicine Business Overview
  124. 6.21.3 PONY Medicine Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 PONY Medicine Pharmaceutical CMC Services Product Portfolio
  126. 6.21.5 PONY Medicine Recent Developments
  127. 6.22 Haoyuan Chemexpress
  128. 6.22.1 Haoyuan Chemexpress Company Information
  129. 6.22.2 Haoyuan Chemexpress Business Overview
  130. 6.22.3 Haoyuan Chemexpress Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Haoyuan Chemexpress Pharmaceutical CMC Services Product Portfolio
  132. 6.22.5 Haoyuan Chemexpress Recent Developments
  133. 6.23 Porton
  134. 6.23.1 Porton Company Information
  135. 6.23.2 Porton Business Overview
  136. 6.23.3 Porton Pharmaceutical CMC Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Porton Pharmaceutical CMC Services Product Portfolio
  138. 6.23.5 Porton Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical CMC Services Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical CMC Services Market Size by Type
  3. 7.2.1 North America Pharmaceutical CMC Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmaceutical CMC Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmaceutical CMC Services Market Share by Type (2021-2032)
  6. 7.3 North America Pharmaceutical CMC Services Market Size by Application
  7. 7.3.1 North America Pharmaceutical CMC Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmaceutical CMC Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmaceutical CMC Services Market Share by Application (2021-2032)
  10. 7.4 North America Pharmaceutical CMC Services Market Size by Country
  11. 7.4.1 North America Pharmaceutical CMC Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmaceutical CMC Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmaceutical CMC Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmaceutical CMC Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical CMC Services Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical CMC Services Market Size by Type
  3. 8.2.1 Europe Pharmaceutical CMC Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmaceutical CMC Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmaceutical CMC Services Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmaceutical CMC Services Market Size by Application
  7. 8.3.1 Europe Pharmaceutical CMC Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmaceutical CMC Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmaceutical CMC Services Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmaceutical CMC Services Market Size by Country
  11. 8.4.1 Europe Pharmaceutical CMC Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmaceutical CMC Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmaceutical CMC Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmaceutical CMC Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmaceutical CMC Services Market Size (2021-2032)
  2. 9.2 China Pharmaceutical CMC Services Market Size by Type
  3. 9.2.1 China Pharmaceutical CMC Services Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmaceutical CMC Services Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmaceutical CMC Services Market Share by Type (2021-2032)
  6. 9.3 China Pharmaceutical CMC Services Market Size by Application
  7. 9.3.1 China Pharmaceutical CMC Services Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmaceutical CMC Services Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmaceutical CMC Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmaceutical CMC Services Market Size (2021-2032)
  2. 10.2 Asia Pharmaceutical CMC Services Market Size by Type
  3. 10.2.1 Asia Pharmaceutical CMC Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmaceutical CMC Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmaceutical CMC Services Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmaceutical CMC Services Market Size by Application
  7. 10.3.1 Asia Pharmaceutical CMC Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmaceutical CMC Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmaceutical CMC Services Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmaceutical CMC Services Market Size by Country
  11. 10.4.1 Asia Pharmaceutical CMC Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmaceutical CMC Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmaceutical CMC Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmaceutical CMC Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmaceutical CMC Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmaceutical CMC Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmaceutical CMC Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmaceutical CMC Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmaceutical CMC Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst